Related references
Note: Only part of the references are listed.Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
K. David Voduc et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers
Sharon Nofech-Mozes et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Molecular Classification of Breast Carcinomas by Immunohistochemical Analysis Are We Ready?
Ping Tang et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2009)
Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel
Ewan K. A. Millar et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis
Pascal Finetti et al.
CANCER RESEARCH (2008)
Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer
Simon J. Crabb et al.
CLINICAL BREAST CANCER (2008)
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy
Paul L. Nguyen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prognostic significance of Nottingham histologic grade in invasive breast carcinoma
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
Giuseppe Viale et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Heterogeneity of breast cancer and implications of adjuvant chemotherapy
A. Rab Razzak et al.
BREAST CANCER (2008)
The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races
Junichi Kurebayashi et al.
BREAST (2007)
Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials
R. Conforti et al.
ANNALS OF ONCOLOGY (2007)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance
Emad A. Rakha et al.
EUROPEAN JOURNAL OF CANCER (2006)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu et al.
BMC GENOMICS (2006)
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
DA Berry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
Stefano Calza et al.
BREAST CANCER RESEARCH (2006)
Proliferation marker Ki-67 in early breast cancer
A Urruticoechea et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy
PT Truong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Ethnicity and breast cancer: Factors influencing differences in incidence and outcome
RT Chlebowski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations
K Yu et al.
CLINICAL CANCER RESEARCH (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies
M Colleoni et al.
ANNALS OF ONCOLOGY (2004)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Pathology characteristics that optimize outcome prediction of a breast screening trial
T. J. Anderson et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
